Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Return on Sales (2020 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Return on Sales for 12 consecutive years, with 0.5% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 104.0% year-over-year to 0.5%, compared with a TTM value of 0.78% through Dec 2025, up 47.0%, and an annual FY2025 reading of 0.4%, up 317.0% over the prior year.
  • Return on Sales was 0.5% for Q4 2025 at Neuroone Medical Technologies, up from 0.59% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.55% in Q4 2024 and bottomed at 131.25% in Q1 2021.
  • Average Return on Sales over 5 years is 29.45%, with a median of 6.53% recorded in 2023.
  • The sharpest move saw Return on Sales plummeted -5577bps in 2021, then skyrocketed 8060bps in 2023.
  • Year by year, Return on Sales stood at 83.19% in 2021, then soared by 82bps to 15.12% in 2022, then skyrocketed by 77bps to 3.42% in 2023, then soared by 116bps to 0.55% in 2024, then crashed by -191bps to 0.5% in 2025.
  • Business Quant data shows Return on Sales for NMTC at 0.5% in Q4 2025, 0.59% in Q3 2025, and 0.88% in Q2 2025.